The Ministry of Health issued a detailed clarification via its official X account stating that reviewing prescriptions and verifying medication safety fall squarely within pharmacists’ duties, in response to an ongoing professional discussion among practitioners. According to the ministry’s post, Article 23 of the Law of Practicing Healthcare Professions mandates that pharmacists must refrain from dispensing any medication if they suspect an error in the prescription and should seek clarification directly from the prescribing physician. The statement further prohibits altering the prescription’s content without the physician’s approval, while allowing for regulatory exceptions involving equivalent therapeutic alternatives.
This clarification underscores the requirement for mutual cooperation between healthcare professionals, as the ministry referenced Article 24 of the same law which demands trust and collaboration while banning any belittling of colleagues. The ministry stressed that all discussions must adhere to scientific principles and professional respect, directing any therapeutic observations through designated official channels rather than public forums. Such measures aim to safeguard patient safety and maintain public confidence in the healthcare team, with violations exposing individuals to regulatory accountability.
The Ministry of Health’s intervention arrived amid heightened attention to medication dispensing practices across the Kingdom, building on its earlier campaigns to enforce compliance. In a February 2026 announcement, the ministry detailed intensified inspection efforts targeting the improper dispensing of antibiotics, weight-loss injections and other restricted drugs without valid prescriptions. Those campaigns, which fall under the Law of Practicing Healthcare Professions and related pharmaceutical regulations, carry penalties including fines of up to 100,000 riyals, temporary facility closures for up to 60 days and potential license revocation.
Regulatory frameworks established by the Saudi Food and Drug Authority further support this pharmacist-led verification process by classifying numerous medications as prescription-only when they present risks of toxicity, interactions or adverse reactions without medical supervision. An assessment published in the journal Natural Resources for Human Health noted that Vision 2030 initiatives have expanded clinical pharmacy roles, integrating e-prescribing systems that enhance pharmacists’ capacity to screen for dosage appropriateness, allergies, therapeutic duplications and patient-specific factors. Clinical pharmacists can now access relevant patient data including laboratory results, medical history and prior prescriptions to ensure safe dispensing.
Complementing these professional obligations, the Ministry of Health operates the Sehhaty digital platform that allows patients to electronically review their issued prescriptions, view medication details and receive adherence reminders. Users can also manually add other medications to their profile for comprehensive tracking, reducing risks associated with incomplete information during pharmacy visits. The service, available through a mobile application, forms part of broader efforts to empower patients while reinforcing the pharmacist’s position as a key checkpoint in the medication-use process.
The unified system for prescribing and dispensing medications, updated through a 2022 ministry decision, explicitly grants specialized clinical pharmacists the right to review patient records for indications, allergies, adverse reaction history and laboratory data before approving any prescription. This authority enables pharmacists to withhold dispensing in cases of incomplete information or potential patient harm until the prescribing physician provides necessary adjustments or alternatives. Such structured protocols align with national goals to minimize medication errors and promote rational drug use across both governmental and private healthcare sectors.
ع